Simplified molecular classification of lung adenocarcinomas based on EGFR, KRAS, and TP53 mutations.

3 b), however, differences between these subtypes when categorized in early stages I and II or late stages III and IV did not reach statistical significance (not shown).

also in 111,027 other papers